Isogenic patient-derived human iPSCs, wild-type or heterozygous for PIK3CA-E418K
Ontology highlight
ABSTRACT: The PIK3CA-related overgrowth syndrome (PROS) patient-derived induced pluripotent stem cell (iPSC) lines M98-WT and M98-E418K were obtained from a female, 18-y-old PROS patient by episomal reprogramming of a dermal fibroblast culture with 32% mosaicism for PIK3CA-E418K heterozygosity. All clones used for experimental studies were confirmed transgene-free and expressed high levels of pluripotent stem cell-specific markers, comparable to those of a reference hPSC line. Karyotyping on a single line from each genotype confirmed lack of microscopic genetic rearrangements. The original patient-derived dermal fibroblasts were obtained with full informed consent in accord with the Declaration of Helsinki. The study was approved by The Cambridge South Ethics.
ORGANISM(S): Homo sapiens
PROVIDER: GSE138161 | GEO | 2019/10/01
REPOSITORIES: GEO
ACCESS DATA